Literature DB >> 2529680

Failure of in vitro assays to predict accurately the existence of neonatally induced H-2 tolerance.

J W Streilein1, P Strome, P J Wood.   

Abstract

Tolerogen-specific alloreactivity, in the form of mixed lymphocyte responses and cell mediated lympholysis, was measured in vitro using lymphocytes from mice that received neonatal inoculations of H-2 semiallogeneic hematopoietic cells. It was found that depletion of specific alloreactivity, as detected by these assays, was discernable within the thymus glands within 24 to 48 hr of injection. Reduced in vitro alloreactivity was also apparent among spleen cells obtained from neonatally injected mice that had matured immunologically (8 weeks of life). In mice that accepted their test skin allografts (in vivo evidence of tolerance), tolerogen-specific activity was essentially undetectable in vitro. Unexpectedly, markedly attenuated MLR and CML activity was the characteristic finding in neonatally injected mice that rejected their test grafts (in vivo evidence of lack of tolerance). Thus, in vitro assays failed to be predictive of the in vivo tolerant state. These results indicate that clonal reduction of tolerogen-reactive cells is an expected and persistent consequence of the injection of tolerance conferring inocula into neonatal mice. Moreover, we believe that the state of tolerance is maintained in adult tolerant mice by mechanisms that cannot easily be studied or predicted by the results of in vitro assays.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2529680

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  14 in total

1.  The influence of donor and recipient strains in isolated small bowel transplantation in rats.

Authors:  M Tanabe; N Murase; A J Demetris; R A Hoffman; K Nakamura; S Fujisaki; F H Galvao; S Todo; J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1994-12       Impact factor: 1.066

2.  Tracking donor-reactive T cells: Evidence for clonal deletion in tolerant kidney transplant patients.

Authors:  Heather Morris; Susan DeWolf; Harlan Robins; Ben Sprangers; Samuel A LoCascio; Brittany A Shonts; Tatsuo Kawai; Waichi Wong; Suxiao Yang; Julien Zuber; Yufeng Shen; Megan Sykes
Journal:  Sci Transl Med       Date:  2015-01-28       Impact factor: 17.956

Review 3.  Mechanism of self-tolerance to endocrine tissue.

Authors:  N N Shehadeh; R G Gill; K J Lafferty
Journal:  Springer Semin Immunopathol       Date:  1993

4.  Lymphocyte changes associated with prolongation of cardiac allograft survival in adult mice using anti-CD4 monoclonal antibody.

Authors:  T C Pearson; A R Bushell; C R Darby; L J West; P J Morris; K J Wood
Journal:  Clin Exp Immunol       Date:  1993-05       Impact factor: 4.330

5.  Impact of donor MHC class I or class II antigen deficiency on first- and second-set rejection of mouse heart or liver allografts.

Authors:  S Qian; F Fu; Y Li; L Lu; A S Rao; T E Starzl; A W Thomson; J J Fung
Journal:  Immunology       Date:  1996-05       Impact factor: 7.397

6.  Immune status of recipients following bone marrow-augmented solid organ transplantation.

Authors:  A Zeevi; M Pavlick; S Lombardozzi; R Banas; O Pappo; A S Rao; P Fontes; J Demetris; R Shapiro; F Dodson
Journal:  Transplantation       Date:  1995-02-27       Impact factor: 4.939

7.  Weaning of immunosuppression in long-term liver transplant recipients.

Authors:  H C Ramos; J Reyes; K Abu-Elmagd; A Zeevi; N Reinsmoen; A Tzakis; A J Demetris; J J Fung; B Flynn; J McMichael
Journal:  Transplantation       Date:  1995-01-27       Impact factor: 4.939

8.  Murine liver allograft transplantation: tolerance and donor cell chimerism.

Authors:  S Qian; A J Demetris; N Murase; A S Rao; J J Fung; T E Starzl
Journal:  Hepatology       Date:  1994-04       Impact factor: 17.425

9.  Presensitization by skin grafting from major histocompatibility complex class I or major histocompatibility complex class II deficient mice identifies class I antigens as inducers of allosensitization.

Authors:  S Qian; F Fu; Y Li; L Gao; L Lu; H Noyola; A S Rao; A W Thomson; J J Fung
Journal:  Immunology       Date:  1995-05       Impact factor: 7.397

10.  Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation.

Authors:  T E Starzl; A J Demetris; M Trucco; A Zeevi; H Ramos; P Terasaki; W A Rudert; M Kocova; C Ricordi; S Ildstad
Journal:  Transplantation       Date:  1993-06       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.